Sanofi - 12 Aug 2024 Form 3 Insider Report for MeiraGTx Holdings plc (MGTX)

Role
10%+ Owner
Signature
/s/ Alexandra Roger, Alexandra Roger, Head of Legal Corporate & Finance
Issuer symbol
MGTX
Transactions as of
12 Aug 2024
Net transactions value
$0
Form type
3
Filing time
13 Aug 2024, 06:30:03 UTC
Previous filing
14 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MGTX Ordinary Shares ($0.00003881 par value per share) 11,500,000 12 Aug 2024 Through its wholly-owned subsidiary, Sanofi Foreign Participations B.V. F1
holding MGTX Ordinary Shares ($0.00003881 par value per share) 697,737 12 Aug 2024 Through its wholly-owned subsidiary Kadmon Corporation, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sanofi is the beneficial owner of Ordinary Shares of the Issuer through its wholly owned subsidiaries Sanofi Foreign Participations B.V. and Kadmon Corporation, LLC.